abstract |
The present invention relates to pyridinecarboxamido-propionic acid derivatives, pharmaceutical compositions containing said derivatives and their usefulness in the treatment and/or prevention of disorders and conditions ameliorated by antagonism of one or more glucagon receptors For use in , disorders and conditions including, for example, metabolic diseases such as type II diabetes and obesity. |